India Viscosupplementation Market Size & Outlook
India viscosupplementation market, 2018-2030 (US$M)
Related Markets
India viscosupplementation market highlights
- The India viscosupplementation market generated a revenue of USD 65.7 million in 2023 and is expected to reach USD 141.0 million by 2030.
- The India market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 65.7 million |
| Market revenue in 2030 | USD 141.0 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, India accounted for 1.4% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 115.5 million by 2030.
Single injection was the largest segment with a revenue share of 42.92% in 2023. Horizon Databook has segmented the India viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
The second highly occurring rheumatologic problem in India is osteoarthritis with a prevalence of 22% - 39%. India has a significant proliferation rate of osteoarthritis in the world and is expected to be among the top ranks in chronic diseases until 2026. However, there are not many studies that have been conducted in the country to provide enough information on OA epidemiology.
Osteoarthritis is more common in women than men are, but the prevalence increases dramatically with age. Around 45% of the women of 65 years and above develop symptoms while radiological evidence is found in 70% of those over 65 years. Knee osteoarthritis is a major factor lying behind mobility impairment among females. It was estimated to be the 10th leading cause of nonfatal burden.
OA of the knees was found to be more prevalent in females (31.6%) than in males (28.1%). This finding is statistically significant. In various studies, it was found that the prevalence of knee osteoarthritis increases with the increase in body mass index (BMI).
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India viscosupplementation market size, by product, 2018-2030 (US$M)
India Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
